Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor,
Recalled June 28, 2023 · FDA recall D-0877-2023 · Aurolife Pharma
Hazard
Failed Impurities/Degradation Specifications · FDA Class III
Sold at
Nationwide within the United States
Description
Failed Impurities/Degradation Specifications
Product
Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
Manufacturer(s)
Aurolife Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →